vs

Side-by-side financial comparison of CapsoVision, Inc (CV) and Valaris Ltd (VAL). Click either name above to swap in a different company.

Valaris Ltd is the larger business by last-quarter revenue ($5.2M vs $3.5M, roughly 1.5× CapsoVision, Inc). Valaris Ltd runs the higher net margin — 13798.1% vs -223.9%, a 14022.0% gap on every dollar of revenue. CapsoVision, Inc produced more free cash flow last quarter ($-5.7M vs $-34.1M).

CapsoVision, Inc. is a medical technology firm specializing in the development and manufacturing of advanced capsule endoscopy systems and supporting diagnostic solutions. Its non-invasive gastrointestinal imaging products are supplied to hospitals, gastroenterology clinics and medical specialists across global markets, supporting more accurate detection of digestive diseases and improved patient care experiences.

Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.

CV vs VAL — Head-to-Head

Bigger by revenue
VAL
VAL
1.5× larger
VAL
$5.2M
$3.5M
CV
Higher net margin
VAL
VAL
14022.0% more per $
VAL
13798.1%
-223.9%
CV
More free cash flow
CV
CV
$28.4M more FCF
CV
$-5.7M
$-34.1M
VAL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CV
CV
VAL
VAL
Revenue
$3.5M
$5.2M
Net Profit
$-7.9M
$717.5M
Gross Margin
54.1%
-7850.0%
Operating Margin
-226.7%
Net Margin
-223.9%
13798.1%
Revenue YoY
405.9%
Net Profit YoY
436.6%
EPS (diluted)
$-0.17
$10.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CV
CV
VAL
VAL
Q4 25
$5.2M
Q3 25
$3.5M
$5.6M
Q2 25
$3.3M
$700.0K
Q4 24
$-1.7M
Q3 24
$3.9M
Q2 24
$4.8M
Q1 24
$2.6M
Q4 23
$3.1M
Net Profit
CV
CV
VAL
VAL
Q4 25
$717.5M
Q3 25
$-7.9M
$188.1M
Q2 25
$-4.6M
$115.1M
Q4 24
$133.7M
Q3 24
$64.6M
Q2 24
$149.6M
Q1 24
$25.5M
Q4 23
$828.5M
Gross Margin
CV
CV
VAL
VAL
Q4 25
-7850.0%
Q3 25
54.1%
-7142.9%
Q2 25
54.6%
-56428.6%
Q4 24
24529.4%
Q3 24
-11748.7%
Q2 24
-9039.6%
Q1 24
-17007.7%
Q4 23
-12867.7%
Operating Margin
CV
CV
VAL
VAL
Q4 25
Q3 25
-226.7%
Q2 25
-140.3%
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Net Margin
CV
CV
VAL
VAL
Q4 25
13798.1%
Q3 25
-223.9%
3358.9%
Q2 25
-139.5%
16442.9%
Q4 24
-7864.7%
Q3 24
1656.4%
Q2 24
3116.7%
Q1 24
980.8%
Q4 23
26725.8%
EPS (diluted)
CV
CV
VAL
VAL
Q4 25
$10.13
Q3 25
$-0.17
$2.65
Q2 25
$-2.02
$1.61
Q4 24
$1.86
Q3 24
$0.88
Q2 24
$2.03
Q1 24
$0.35
Q4 23
$11.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CV
CV
VAL
VAL
Cash + ST InvestmentsLiquidity on hand
$599.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.4M
$3.2B
Total Assets
$25.7M
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CV
CV
VAL
VAL
Q4 25
$599.4M
Q3 25
$662.7M
Q2 25
$503.4M
Q4 24
$368.2M
Q3 24
$379.3M
Q2 24
$398.3M
Q1 24
$494.1M
Q4 23
$620.5M
Stockholders' Equity
CV
CV
VAL
VAL
Q4 25
$3.2B
Q3 25
$20.4M
$2.4B
Q2 25
$-139.0M
$2.3B
Q4 24
$2.2B
Q3 24
$2.1B
Q2 24
$2.2B
Q1 24
$2.0B
Q4 23
$2.0B
Total Assets
CV
CV
VAL
VAL
Q4 25
$5.3B
Q3 25
$25.7M
$4.6B
Q2 25
$9.5M
$4.5B
Q4 24
$4.4B
Q3 24
$4.3B
Q2 24
$4.4B
Q1 24
$4.4B
Q4 23
$4.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CV
CV
VAL
VAL
Operating Cash FlowLast quarter
$-5.7M
$72.2M
Free Cash FlowOCF − Capex
$-5.7M
$-34.1M
FCF MarginFCF / Revenue
-160.5%
-655.8%
Capex IntensityCapex / Revenue
0.3%
2044.2%
Cash ConversionOCF / Net Profit
0.10×
TTM Free Cash FlowTrailing 4 quarters
$159.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CV
CV
VAL
VAL
Q4 25
$72.2M
Q3 25
$-5.7M
$198.1M
Q2 25
$-9.5M
$120.0M
Q4 24
$124.6M
Q3 24
$193.0M
Q2 24
$11.5M
Q1 24
$26.3M
Q4 23
$96.7M
Free Cash Flow
CV
CV
VAL
VAL
Q4 25
$-34.1M
Q3 25
$-5.7M
$128.3M
Q2 25
$-9.6M
$52.8M
Q4 24
$12.9M
Q3 24
$111.1M
Q2 24
$-98.7M
Q1 24
$-125.0M
Q4 23
$-366.3M
FCF Margin
CV
CV
VAL
VAL
Q4 25
-655.8%
Q3 25
-160.5%
2291.1%
Q2 25
-289.0%
7542.9%
Q4 24
-758.8%
Q3 24
2848.7%
Q2 24
-2056.3%
Q1 24
-4807.7%
Q4 23
-11816.1%
Capex Intensity
CV
CV
VAL
VAL
Q4 25
2044.2%
Q3 25
0.3%
1246.4%
Q2 25
2.1%
9600.0%
Q4 24
-6570.6%
Q3 24
2100.0%
Q2 24
2295.8%
Q1 24
5819.2%
Q4 23
14935.5%
Cash Conversion
CV
CV
VAL
VAL
Q4 25
0.10×
Q3 25
1.05×
Q2 25
1.04×
Q4 24
0.93×
Q3 24
2.99×
Q2 24
0.08×
Q1 24
1.03×
Q4 23
0.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CV
CV

Products$2.5M71%
Other$1.0M29%

VAL
VAL

Segment breakdown not available.

Related Comparisons